Midday administration (46 hours post 5-Amino-1MQ): MOTS-c 510mg subcutaneously
Abstract Significance: The antiulcer peptide, stable gastric pentadecapeptide BPC 157 (previously employed in ulcerative colitis and multiple sclerosis trials, no reported toxicity (LD1 not achieved)), is reviewed, focusing on the particular skin wound therapy, incisional/excisional wound, deep burns, diabetic ulcers, and alkali burns, which may be generalized to the other tissues healing
BPC-157 is a tissue repair research compound commonly evaluated in studies focused on tissue repair, tendon, ligament, and gastrointestinal pathway research
Its primary benefit is promoting faster wound healing and recovery by encouraging cell migration to the site of an injury